BR9606823A - Hidroximetil-imidazoazepinas e seus èsteres - Google Patents

Hidroximetil-imidazoazepinas e seus èsteres

Info

Publication number
BR9606823A
BR9606823A BR9606823A BR9606823A BR9606823A BR 9606823 A BR9606823 A BR 9606823A BR 9606823 A BR9606823 A BR 9606823A BR 9606823 A BR9606823 A BR 9606823A BR 9606823 A BR9606823 A BR 9606823A
Authority
BR
Brazil
Prior art keywords
hydroxymethyl
esters
imidazoazepines
imidazodiazepines
anxiolytic
Prior art date
Application number
BR9606823A
Other languages
English (en)
Inventor
Rene Borer
Bernd Buettelmann
Max Gerecke
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9606823A publication Critical patent/BR9606823A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
BR9606823A 1995-01-06 1996-01-03 Hidroximetil-imidazoazepinas e seus èsteres BR9606823A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2895 1995-01-06
PCT/CH1996/000001 WO1996020941A1 (de) 1995-01-06 1996-01-03 Hydroxymethyl-imidazodiazepine und deren ester

Publications (1)

Publication Number Publication Date
BR9606823A true BR9606823A (pt) 1997-12-30

Family

ID=4177731

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606823A BR9606823A (pt) 1995-01-06 1996-01-03 Hidroximetil-imidazoazepinas e seus èsteres

Country Status (16)

Country Link
US (1) US6174881B1 (pt)
EP (1) EP0801651B1 (pt)
JP (1) JP3001979B2 (pt)
CN (1) CN1168140A (pt)
AT (1) ATE203026T1 (pt)
AU (1) AU4296196A (pt)
BR (1) BR9606823A (pt)
CA (1) CA2209424A1 (pt)
DE (1) DE59607274D1 (pt)
DK (1) DK0801651T3 (pt)
ES (1) ES2159714T3 (pt)
FI (1) FI972865A (pt)
GR (1) GR3036867T3 (pt)
PT (1) PT801651E (pt)
TR (1) TR199700587T1 (pt)
WO (1) WO1996020941A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444664B1 (en) 1997-04-18 2002-09-03 Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
EP0875247B1 (en) * 1997-04-18 2003-05-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for controlling the plasma level of lipoproteins
ES2189759T3 (es) * 1999-05-12 2003-07-16 Hoffmann La Roche Derivados de imidazoiacepina.
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
TWI232863B (en) 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
SK287583B6 (sk) 2001-06-14 2011-03-04 N.V. Organon (Pyrido/tieno)-[f]-oxazepin-5-ónové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
ATE480532T1 (de) 2006-07-10 2010-09-15 Paion Uk Ltd Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
GB0613693D0 (en) 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
CA2696703C (en) 2007-08-20 2016-07-26 Evotec Neurosciences Gmbh Treatment of sleep disorders
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
KR101857599B1 (ko) 2010-05-14 2018-05-14 다나-파버 캔서 인스티튜트 인크. 종양형성, 염증성 질환 및 다른 장애를 치료하기 위한 조성물 및 방법
WO2011143660A2 (en) 2010-05-14 2011-11-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
WO2013174883A1 (en) 2012-05-22 2013-11-28 Paion Uk Limited Compositions comprising short-acting benzodiazepines
CN103012408B (zh) * 2012-11-28 2015-02-04 中国科学院广州生物医药与健康研究院 依匹斯汀的合成方法
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
BR112016001457A2 (pt) 2013-07-25 2017-08-29 Dana Farber Cancer Inst Inc Inibidores de fatores de transcrição e usos dos mesmos
US11446309B2 (en) 2013-11-08 2022-09-20 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
JP2017504653A (ja) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ジアミノピリミジンベンゼンスルホン誘導体およびその使用
JP2017504651A (ja) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド ジアゼパン誘導体の使用
US10925881B2 (en) 2014-02-28 2021-02-23 Tensha Therapeutics, Inc. Treatment of conditions associated with hyperinsulinaemia
EP4299126A3 (en) 2014-06-26 2024-04-03 The Johns Hopkins University Peripherally restricted gaba positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system
CA2955077A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
WO2016022902A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
AU2015339511B2 (en) 2014-10-27 2020-05-14 Tensha Therapeutics, Inc. Bromodomain inhibitors
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. ASSOCIATION THERAPY USING TRANSCRIPTION INHIBITORS AND KINASE INHIBITORS
RU2750164C2 (ru) 2015-09-11 2021-06-22 Дана-Фарбер Кэнсер Инститьют, Инк. Цианотиенотриазолодиазепины и пути их применения
KR20180051576A (ko) 2015-09-11 2018-05-16 다나-파버 캔서 인스티튜트 인크. 아세트아미드 티에노트리아졸로디아제핀 및 그의 용도
WO2017091673A2 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibtors and uses thereof
CN109641000A (zh) 2016-04-14 2019-04-16 Paion英国有限公司 经口吸入和经鼻用的苯并二氮杂*类
CN107325101B (zh) * 2017-06-29 2019-03-26 上海合全药物研发有限公司 6-羟甲基-6,7-二氢-5h,9h-咪唑并二氮杂卓-8-羧酸叔丁酯的合成方法
CN113087713B (zh) * 2021-03-29 2022-10-04 中国人民解放军军事科学院军事医学研究院 一类苯并二氮䓬衍生物及其制备方法和用途
USD1023445S1 (en) * 2022-03-03 2024-04-16 Elc Management Llc Cosmetic applicator
USD1017893S1 (en) * 2022-03-03 2024-03-12 Elc Management Llc Cosmetic applicator

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902794A (en) * 1971-04-28 1990-02-20 The Upjohn Company Triazolo-benzodiazepines
US3763179A (en) * 1972-05-05 1973-10-02 Upjohn Co 2-imidazol-1-yl benzophenones
US4280957A (en) * 1974-09-11 1981-07-28 Hoffmann-La Roche Inc. Imidazodiazepines and processes therefor
DE2547652A1 (de) * 1974-11-15 1976-05-20 Upjohn Co Pharmazeutische zubereitung
DE3432974A1 (de) * 1983-09-12 1985-04-04 The Upjohn Co., Kalamazoo, Mich. Arzneimittel zur prophylaxe oder therapie der negativen shizophreniesymtome bei menschen
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US5439906A (en) 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
CA2176020A1 (en) 1993-11-22 1995-06-01 John J. Baldwin Benzodiazepines

Also Published As

Publication number Publication date
DK0801651T3 (da) 2001-10-22
CN1168140A (zh) 1997-12-17
ATE203026T1 (de) 2001-07-15
MX9705061A (es) 1997-10-31
EP0801651B1 (de) 2001-07-11
JPH10500998A (ja) 1998-01-27
FI972865A (fi) 1997-09-03
WO1996020941A1 (de) 1996-07-11
AU4296196A (en) 1996-07-24
US6174881B1 (en) 2001-01-16
TR199700587T1 (xx) 1998-02-21
ES2159714T3 (es) 2001-10-16
PT801651E (pt) 2001-12-28
JP3001979B2 (ja) 2000-01-24
EP0801651A1 (de) 1997-10-22
GR3036867T3 (en) 2002-01-31
FI972865A0 (fi) 1997-07-04
CA2209424A1 (en) 1996-07-11
DE59607274D1 (de) 2001-08-16

Similar Documents

Publication Publication Date Title
BR9606823A (pt) Hidroximetil-imidazoazepinas e seus èsteres
ATE182892T1 (de) Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren
PT970095E (pt) Novos inibidores benzimidazole de frutose-1,6-bisfosfatase
DE69620161T2 (de) Thrombininhibitoren
FI935585A (fi) Pyrrolopyrimidiinit
DE69528528T2 (de) Thrombin-inhibitoren
FI962218A (fi) H2-pitoisen kaasun valmistaminen
FI945434A0 (fi) 4-markatpoasetyyliamino/2/bentsatsepinoni (3) johdannaisia ja niiden käyttö enkefalinaasi-inhibiittoreina
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
FI963613A (fi) Polyolefiinien stabilointi
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
FI962481A0 (fi) 4-bentsoyyli-isokatsolit ja niiden käyttö herbisideinä
MX9703288A (es) Oxazolil- y tiazolilimidazo-benzo- y tienodiacepinas y su uso como medicamentos.
NO952949D0 (no) Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider
DE69430545T2 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
FI970064A0 (fi) Foermedling av en galvaniskt isolerad styrningssignal mellan primaer- och sekundaersidan i en effektkaella
SU1732643A1 (ru) Амиды n-этоксиоксалилантраниловой кислоты, проявляющие противовоспалительную и анальгетическую активность
SE9503658D0 (sv) Lagring av axlar medelst fjädrande busning
FI940561A0 (fi) Minskning av imbildning i bilar
KR970040793U (ko) 연소실의 냉각장치
ECSP951578A (es) Oxazolyl y thiazolylimidazo- benzo- y thienodiazepines,
FI995U1 (fi) Hjulburen anordning foer anvaendning i traedgaordar och liknande
IT1276751B1 (it) Composti ad attivita' antitumorale
KR950002507U (ko) 앰프케이스의 조립구조체

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements